Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Dyne Therapeutics
DYN
$4.85B
| $2.99M | ﹤0.01% |
184,183
+32,557
| +21% | +$577K |
|
|
CCC
2602
CCC Intelligent Solutions
CCC
$4.19B
| $2.99M | ﹤0.01% |
+284,517
| New | +$2.94M |
|
2603
Regional Management Corp
RM
$301M
| $2.99M | ﹤0.01% |
51,327
-1,358
| -3% | -$74.9K |
|
2604
Stratasys
SSYS
$779M
| $2.98M | ﹤0.01% |
138,424
+493
| +0.4% | +$10.7K |
|
|
HYZN
2605
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $2.98M | ﹤0.01% |
+8,580
| New | +$3.72M |
|
2606
Xometry
XMTR
$5.42B
| $2.97M | ﹤0.01% |
+51,516
| New | +$3.57M |
|
|
FSP
2607
Franklin Street Properties
FSP
$46.4M
| $2.96M | ﹤0.01% |
638,670
-46,102
| -7% | -$225K |
|
|
RJET
2608
Republic Airways Holdings
RJET
$964M
| $2.96M | ﹤0.01% |
25,751
+6,519
| +34% | +$811K |
|
2609
Taysha Gene Therapies
TSHA
$1.92B
| $2.95M | ﹤0.01% |
158,407
+71,377
| +82% | +$1.36M |
|
2610
Vital Farms
VITL
$498M
| $2.95M | ﹤0.01% |
167,845
+41,222
| +33% | +$740K |
|
2611
Oppenheimer Holdings
OPY
$1.23B
| $2.92M | ﹤0.01% |
64,392
-37
| -0.1% | -$1.66K |
|
2612
Ouster
OUST
$3.25B
| $2.91M | ﹤0.01% |
39,737
+380
| +1% | +$35K |
|
2613
MetroCity Bankshares
MCBS
$1.05B
| $2.9M | ﹤0.01% |
138,213
+6,524
| +5% | +$130K |
|
2614
Tejon Ranch
TRC
$443M
| $2.87M | ﹤0.01% |
161,673
+19,303
| +14% | +$343K |
|
|
RFP
2615
DELISTED
Resolute Forest Products Inc.
RFP
| $2.86M | ﹤0.01% |
240,470
-139,706
| -37% | -$1.63M |
|
2616
iShares MSCI EAFE ETF
EFA
$80.3B
| $2.83M | ﹤0.01% |
36,330
-4,321
| -11% | -$346K |
|
2617
TAL Education Group
TAL
$6.43B
| $2.83M | ﹤0.01% |
585,064
+12,415
| +2% | +$110K |
|
2618
Erasca
ERAS
$6.25B
| $2.83M | ﹤0.01% |
+133,395
| New | +$2.75M |
|
2619
Tredegar Corp
TG
$278M
| $2.78M | ﹤0.01% |
228,538
-65,519
| -22% | -$840K |
|
|
LTRPA
2620
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $2.76M | ﹤0.01% |
893,786
-274,179
| -23% | -$1.02M |
|
|
VEI
2621
DELISTED
Vine Energy Inc.
VEI
| $2.75M | ﹤0.01% |
167,080
+11,957
| +8% | +$179K |
|
2622
MediaAlpha
MAX
$813M
| $2.75M | ﹤0.01% |
147,164
-2,458
| -2% | -$66.6K |
|
2623
Nkarta
NKTX
$165M
| $2.73M | ﹤0.01% |
98,073
-9,542
| -9% | -$302K |
|
|
VIEW
2624
DELISTED
View, Inc. Class A Common Stock
VIEW
| $2.72M | ﹤0.01% |
8,360
+513
| +7% | +$180K |
|
|
SDC
2625
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $2.71M | ﹤0.01% |
509,603
+88,274
| +21% | +$548K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.